vs
Indivior Pharmaceuticals, Inc.（INDV）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
Reddit, Inc.的季度营收约是Indivior Pharmaceuticals, Inc.的1.9倍（$663.0M vs $357.0M），Reddit, Inc.净利率更高（30.8% vs 28.9%，领先1.9%），Reddit, Inc.自由现金流更多（$311.0M vs $-245.0M）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
INDV vs RDDT — 直观对比
营收规模更大
RDDT
是对方的1.9倍
$357.0M
净利率更高
RDDT
高出1.9%
28.9%
自由现金流更多
RDDT
多$556.0M
$-245.0M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $663.0M |
| 净利润 | $103.0M | $204.0M |
| 毛利率 | 82.1% | 100.0% |
| 营业利润率 | 22.7% | 0.0% |
| 净利率 | 28.9% | 30.8% |
| 营收同比 | — | 69.0% |
| 净利润同比 | 390.5% | 680.0% |
| 每股收益（稀释后） | $0.79 | $1.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVRDDT
| Q1 26 | — | $663.0M | ||
| Q4 25 | $357.0M | $725.6M | ||
| Q3 25 | $314.0M | $584.9M | ||
| Q2 25 | $302.0M | $499.6M | ||
| Q1 25 | $266.0M | $392.4M | ||
| Q4 24 | — | $427.7M | ||
| Q3 24 | $307.0M | $348.4M | ||
| Q2 24 | $299.0M | $281.2M |
净利润INDVRDDT
| Q1 26 | — | $204.0M | ||
| Q4 25 | $103.0M | $251.6M | ||
| Q3 25 | $42.0M | $162.7M | ||
| Q2 25 | $18.0M | $89.3M | ||
| Q1 25 | $47.0M | $26.2M | ||
| Q4 24 | — | $71.0M | ||
| Q3 24 | $22.0M | $29.9M | ||
| Q2 24 | $-97.0M | $-10.1M |
毛利率INDVRDDT
| Q1 26 | — | 100.0% | ||
| Q4 25 | 82.1% | 91.9% | ||
| Q3 25 | 73.2% | 91.0% | ||
| Q2 25 | 82.8% | 90.8% | ||
| Q1 25 | 83.1% | 90.5% | ||
| Q4 24 | — | 92.6% | ||
| Q3 24 | 78.5% | 90.1% | ||
| Q2 24 | 73.6% | 89.5% |
营业利润率INDVRDDT
| Q1 26 | — | 0.0% | ||
| Q4 25 | 22.7% | 31.9% | ||
| Q3 25 | 13.7% | 23.7% | ||
| Q2 25 | 23.8% | 13.6% | ||
| Q1 25 | 24.8% | 1.0% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | 11.4% | 2.0% | ||
| Q2 24 | -39.5% | -11.0% |
净利率INDVRDDT
| Q1 26 | — | 30.8% | ||
| Q4 25 | 28.9% | 34.7% | ||
| Q3 25 | 13.4% | 27.8% | ||
| Q2 25 | 6.0% | 17.9% | ||
| Q1 25 | 17.7% | 6.7% | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | 7.2% | 8.6% | ||
| Q2 24 | -32.4% | -3.6% |
每股收益（稀释后）INDVRDDT
| Q1 26 | — | $1.01 | ||
| Q4 25 | $0.79 | $1.24 | ||
| Q3 25 | $0.33 | $0.80 | ||
| Q2 25 | $0.14 | $0.45 | ||
| Q1 25 | $0.38 | $0.13 | ||
| Q4 24 | — | $4.76 | ||
| Q3 24 | $0.16 | $0.16 | ||
| Q2 24 | $-0.72 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $3.2B |
| 总资产 | $1.2B | $3.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVRDDT
| Q1 26 | — | $1.4B | ||
| Q4 25 | $195.0M | $953.6M | ||
| Q3 25 | $445.0M | $911.7M | ||
| Q2 25 | $510.0M | $734.1M | ||
| Q1 25 | $373.0M | $635.7M | ||
| Q4 24 | — | $562.1M | ||
| Q3 24 | — | $515.9M | ||
| Q2 24 | — | $468.0M |
股东权益INDVRDDT
| Q1 26 | — | $3.2B | ||
| Q4 25 | $-98.0M | $2.9B | ||
| Q3 25 | $-207.0M | $2.6B | ||
| Q2 25 | $-257.0M | $2.4B | ||
| Q1 25 | $-285.0M | $2.2B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $-310.0M | $2.0B | ||
| Q2 24 | $-281.0M | $1.9B |
总资产INDVRDDT
| Q1 26 | — | $3.5B | ||
| Q4 25 | $1.2B | $3.2B | ||
| Q3 25 | $1.4B | $2.9B | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.4B | $2.4B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $311.0M |
| 自由现金流率自由现金流/营收 | -68.6% | 46.9% |
| 资本支出强度资本支出/营收 | 6.7% | — |
| 现金转化率经营现金流/净利润 | -2.15× | — |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $868.6M |
8季度趋势，按日历期对齐
经营现金流INDVRDDT
| Q1 26 | — | — | ||
| Q4 25 | $-221.0M | $266.8M | ||
| Q3 25 | $-39.0M | $185.2M | ||
| Q2 25 | $158.0M | $111.3M | ||
| Q1 25 | $75.0M | $127.6M | ||
| Q4 24 | — | $90.0M | ||
| Q3 24 | $2.0M | $71.6M | ||
| Q2 24 | $88.0M | $28.4M |
自由现金流INDVRDDT
| Q1 26 | — | $311.0M | ||
| Q4 25 | $-245.0M | $263.6M | ||
| Q3 25 | $-59.0M | $183.1M | ||
| Q2 25 | $141.0M | $110.8M | ||
| Q1 25 | $70.0M | $126.6M | ||
| Q4 24 | — | $89.2M | ||
| Q3 24 | $-5.0M | $70.3M | ||
| Q2 24 | $84.0M | $27.2M |
自由现金流率INDVRDDT
| Q1 26 | — | 46.9% | ||
| Q4 25 | -68.6% | 36.3% | ||
| Q3 25 | -18.8% | 31.3% | ||
| Q2 25 | 46.7% | 22.2% | ||
| Q1 25 | 26.3% | 32.3% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | -1.6% | 20.2% | ||
| Q2 24 | 28.1% | 9.7% |
资本支出强度INDVRDDT
| Q1 26 | — | — | ||
| Q4 25 | 6.7% | 0.4% | ||
| Q3 25 | 6.4% | 0.4% | ||
| Q2 25 | 5.6% | 0.1% | ||
| Q1 25 | 1.9% | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 2.3% | 0.4% | ||
| Q2 24 | 1.3% | 0.4% |
现金转化率INDVRDDT
| Q1 26 | — | — | ||
| Q4 25 | -2.15× | 1.06× | ||
| Q3 25 | -0.93× | 1.14× | ||
| Q2 25 | 8.78× | 1.25× | ||
| Q1 25 | 1.60× | 4.88× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | 0.09× | 2.40× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
RDDT
暂无分部数据
